From: TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma
Characteristic | mRNA cohort | Protein cohort | ||
---|---|---|---|---|
3-year DSS (%) | P a | 3-year DSS (%) | P a | |
TRPV6 expression | Ā | 0.531 | Ā | 0.244 |
āDownregulation | 53.8 | Ā | 34.0 | Ā |
āNormal expression | 59.6 | Ā | 42.9 | Ā |
Age | Ā | 0.145 | Ā | 0.448 |
āāā¤ā58 | 60.6 | Ā | 38.9 | Ā |
āā>ā58 | 55.3 | Ā | 38.1 | Ā |
Gender | Ā | 0.653 | Ā | 0.880 |
āMale | 58.1 | Ā | 40.2 | Ā |
āFemale | 55.9 | Ā | 37.2 | Ā |
Location | Ā | 0.545 | Ā | 0.428 |
āUpper | 64.4 | Ā | 30.6 | Ā |
āMiddle | 56.1 | Ā | 40.1 | Ā |
āLower | 55.2 | Ā | 47.1 | Ā |
Differentiation | Ā | 0.330 | Ā | 0.010 |
āGrade 1 | 62.6 | Ā | 54.2 | Ā |
āGrade 2 | 60.7 | Ā | 40.8 | Ā |
āGrade 3 | 45.4 | Ā | 23.4 | Ā |
pT category | Ā | 0.040 | Ā | 0.002 |
āT1ā2 | 66.4 | Ā | 52.5 | Ā |
āT3ā4 | 55.6 | Ā | 30.4 | Ā |
pN category | Ā | <0.001 | Ā | <0.001 |
āN0 | 74.0 | Ā | 54.0 | Ā |
āN1ā3 | 37.5 | Ā | 18.1 | Ā |
Pathological staging | Ā | <0.001 | Ā | <0.001 |
āIāII | 72.1 | Ā | 53.3 | Ā |
āIII | 37.5 | Ā | 13.6 | Ā |